Approvals/TGA/CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial

Approved

STANDARD

CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 14bb6954d8e1c167
Product Name: CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial
Artg Id: 227352
Artg Name: CYRAMZA ramucirumab 500 mg/50 mL solution for intravenous infusion vial
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2015-07-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a1335f7dab10b731cde1e8a9c32b2b75.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/be15beca7912b200ddd42e441ccd0887.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

14bb6954d8e1c167

Type

Standard